Treatment of Panic Disorder Among Individuals Consulting Emergency Departments for Non Cardiac Chest Pain (MADONA)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00736346 |
Recruitment Status
: Unknown
Verified August 2008 by Universite du Quebec a Montreal.
Recruitment status was: Recruiting
First Posted
: August 15, 2008
Last Update Posted
: August 15, 2008
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Panic Disorder Anxiety Disorder Mental Disorder | Behavioral: Brief cognitive-behavioral treatment for Panic Disorder Behavioral: Cognitive-Behavior Therapy for Panic Disorder Drug: paroxetine | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 204 participants |
Allocation: | Non-Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Efficacy of Three Treatment Modalities for Panic Disorder Among Individuals Consulting Emergency Departments for Non Cardiac Chest Pain |
Study Start Date : | October 2005 |
Estimated Primary Completion Date : | December 2009 |
Estimated Study Completion Date : | June 2010 |
Arm | Intervention/treatment |
---|---|
Active Comparator: 1 |
Behavioral: Brief cognitive-behavioral treatment for Panic Disorder
One two-hour session of cognitive-behavior therapy for panic disorder
|
Active Comparator: 2 |
Behavioral: Cognitive-Behavior Therapy for Panic Disorder
Seven one-hour sessions of cognitive-behavior therapy for panic disorder
|
Active Comparator: 3 |
Drug: paroxetine
40 mg die, for 6 months
|
No Intervention: 4 |
- Panic Disorder diagnosis [ Time Frame: Pre and posttreatment, and 3, 6 and 12 months after treament ]
- Panic symptomatology, psychological distress, quality of life, and use of health services [ Time Frame: Pre and posttreatment, and 3, 6 and 12 months after treatment ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Aged 18 and over
- Mastered oral and written French
- Consulted an emergency department for chest pain with very low risk of coronary disease (normal ECG and blood tests)
- Met criteria for Panic Disorder
Exclusion Criteria:
- Chest pain with an obvious medical origin (obvious trauma or abnormal pulmonary x-rays)
- Had received cognitive-behavior therapy for Panic Disorder in the last six months
- Cognitive impairment preventing the completion of psychological assessment
- Past or present psychotic episode, Bipolar Disorder, or organic mental disorder
- Current Abuse or Dependence Disorder
- If another Mental Disorder is present, its severity was equal or inferior to the severity of Panic Disorder
- Current medical condition preventing the participant from receiving pharmacological of cognitive-behavior treatment

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00736346
Contact: André Marchand, PhD | 1 (514) 987-3000 ext 8439 | marchand.andre@uqam.ca | |
Contact: Geneviève Belleville, PhD | belleville.genevieve@uqam.ca |
Canada, Quebec | |
Hôtel-Dieu de Lévis | Recruiting |
Lévis, Quebec, Canada, G6V 3Z1 | |
Contact: Julien Poitras, MD | |
Institut de Cardiologie de Montréal (Montreal Heart Institute) | Recruiting |
Montréal, Quebec, Canada, H1T 1C8 | |
Contact: Alain Vadeboncoeur, MD | |
Hôpital du Sacré-Coeur de Montréal | Recruiting |
Montréal, Quebec, Canada, H4J 1C5 | |
Contact: Jean-Marc Chauny, MD |
Principal Investigator: | André Marchand, PhD | Universite du Quebec a Montreal |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | André Marchand, UQAM |
ClinicalTrials.gov Identifier: | NCT00736346 History of Changes |
Other Study ID Numbers: |
MOP 81128 (CIHR) |
First Posted: | August 15, 2008 Key Record Dates |
Last Update Posted: | August 15, 2008 |
Last Verified: | August 2008 |
Keywords provided by Universite du Quebec a Montreal:
Panic Disorder anxiety chest pain emergency department cognitive-behavioral treatment |
Additional relevant MeSH terms:
Disease Emergencies Anxiety Disorders Chest Pain Mental Disorders Psychotic Disorders Panic Disorder Pathologic Processes Disease Attributes Pain Neurologic Manifestations Nervous System Diseases Signs and Symptoms Schizophrenia Spectrum and Other Psychotic Disorders |
Paroxetine Serotonin Uptake Inhibitors Neurotransmitter Uptake Inhibitors Membrane Transport Modulators Molecular Mechanisms of Pharmacological Action Neurotransmitter Agents Serotonin Agents Physiological Effects of Drugs Antidepressive Agents, Second-Generation Antidepressive Agents Psychotropic Drugs Cytochrome P-450 CYP2D6 Inhibitors Cytochrome P-450 Enzyme Inhibitors Enzyme Inhibitors |